8,700 Studies Reviewed. 87.0% Found Biological Effects. The Evidence is Clear.
Shield Your Body
Cancer & Tumors

Differences in DMBA-induced mammary neoplastic responses in two lines of Sprague-Dawley rats

Bioeffects Seen

Authors not listed · 1984

Share:

Genetic differences between laboratory rat populations caused four-fold variations in cancer rates, highlighting individual susceptibility differences.

Plain English Summary

Summary written for general audiences

Researchers compared cancer responses in two genetically different lines of Sprague-Dawley rats using the chemical carcinogen DMBA. American rats developed mammary tumors at rates of 90-100%, while Dutch rats showed only 25% tumor rates, revealing significant genetic differences in cancer susceptibility between laboratory animal populations.

Why This Matters

This 1984 study reveals a critical issue in EMF research that persists today: genetic variability dramatically affects biological responses to harmful exposures. The four-fold difference in cancer rates between rat populations demonstrates why some EMF studies show conflicting results. When American rats developed tumors at 90-100% rates compared to just 25% in Dutch rats, it highlighted how genetic background influences susceptibility to carcinogenic exposures. This same principle applies to EMF research, where population genetics, age, and individual susceptibility factors can mask or amplify radiation effects. The reality is that standardized laboratory conditions don't eliminate the fundamental biological truth that some individuals are more vulnerable to environmental toxins than others.

Exposure Information

Specific exposure levels were not quantified in this study.

Cite This Study
Unknown (1984). Differences in DMBA-induced mammary neoplastic responses in two lines of Sprague-Dawley rats.
Show BibTeX
@article{differences_in_dmba_induced_mammary_neoplastic_responses_in_two_lines_of_sprague_dawley_rats_ce2275,
  author = {Unknown},
  title = {Differences in DMBA-induced mammary neoplastic responses in two lines of Sprague-Dawley rats},
  year = {1984},
  doi = {10.1016/0277-5379(84)90130-5},
  
}
DOI: 10.1016/0277-5379(84)90130-5PubMed: 6434314

Quick Questions About This Study

The two rat populations had different genetic backgrounds, confirmed by blood antigen testing. American rats were inherently more susceptible to developing mammary tumors when exposed to the same carcinogenic chemical dose.
DMBA studies demonstrate how genetic differences between test populations can create vastly different responses to the same harmful exposure, explaining why EMF studies sometimes show conflicting results across different laboratories.
American rats developed mammary carcinomas at 90-100% rates while Dutch rats showed only 25% rates - a four-fold difference from the same chemical exposure, proving genetics dramatically influences cancer susceptibility.
Yes, American rats developed fibroadenomas at 83-95% rates compared to just 18% in Dutch rats, showing that genetic background influenced both malignant carcinomas and benign tumor development patterns.
Researchers tested blood cell antigens controlled by the RT1 major histocompatibility complex and found distinct genetic markers, proving the American and Dutch rat lines were genetically separate populations.